News
Healthcare workers at six health systems across the country have launched strikes in July so far. These healthcare employees ...
CMS proposed a 2.4% Medicare payment increase for hospitals’ outpatient departments and ambulatory surgery centers in 2026, ...
Numerous advocacy organizations are sounding the alarm over a recent HHS notice that restricts access to federal benefits for ...
Healthcare providers are making cybersecurity progress, but serious vulnerabilities remain — especially when it comes to AI ...
Opinion
GLP-1s, Personalization, and Big Pharma Power Plays: What’s Really at Stake in the Eli Lilly Lawsuit
This lawsuit may look like a business dispute on the surface. But underneath, it’s about something much more important: the right of patients to receive personalized, affordable care.
A bill introduced by Rep. Earl L. "Buddy" Carter would ban PBMs’ use of spread pricing in Medicaid, among other reforms.
Verona Pharma brings to Merck the inhaled drug Ohtuvayre, which is FDA approved as a treatment for chronic obstructive ...
At the heart of this fight are the patients whose lives quite literally depend on Medicaid. But we are also fighting for the caregivers who show up every day, the children who rely on stability ...
Sarepta Therapeutics knew about the death of a patient treated with its experimental gene therapy for a type of limb-girdle muscular dystrophy, but said nothing publicly for a month. Financial ...
A group of Democratic attorneys general filed a lawsuit against HHS and CMS, arguing that their recent final rule will harm access to care under the Affordable Care Act.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results